Annual Report for the FY 2025-26.

Date: 01.09.2026 BSE Limited P.J. Towers, Dalal Street Mumbai — 400001 Dear Sir/Madam, Sub: Submission of Notice of the Annual General Meeting and Annual Report for the Financial Year 2025-26 pursuant to Regulations 30 and 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Unit: Bandaram Pharma Packtech Limited (Scrip Code 524602) With reference to the subject cited above and pursuant to Regulations 30 and 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the Notice of the Annual General Meeting and the Annual Report of the Company for the Financial Year 2025-26. The Annual General Meeting ("AGM") of the Company is scheduled to be held on Thursday, September 24, 2026, at 11:00 A.M. (IST) through Video Conferencing ("VC") / Other Audio-Visual Means ("OAVM"). The Annual General Meeting of the Company was initially scheduled to be held on Friday, 18th September 2026 at 11.00 a.m. In view of certain circumstances, the Annual General Meeting was postponed and rescheduled to be held on Thursday, 24th September 2026 at 11.00 a.m. The consent of the Board for the postponement of the Annual General Meeting was obtained by way of a Circular Resolution pursuant to the provisions of Section 175 of the Companies Act, 2013. CIN: L93090KA1993PLC159827 www.bandaram.com, Reg office. The cut-off date for the same is Thursday, 17th September 2026. This is for the information and records of the Exchange, please. Thanking you. Yours sincerely, For Bandaram Pharma Packtech Limited Deepak Reddy Bandaram Chairman and Managing Director (DIN: 07074102) As encl. above CIN: L93090KA1993PLC159827 www.bandaram.com, Reg office. BANDARAM PHARMA PACKTECH LIMITED ANNUAL REPORT FOR THE FINANCIAL YEAR 2025-26 BANDARAM PHARMA PACKTECH LIMITED CORPORATE INFORMATION BOARD OF DIRECTORS 1. Mr. Deepak Reddy Bandaram - Chairman and Managing Director (DIN: 07074102) 2. Mr. Bhandaram Premsai Reddy - Non - Executive Director (DIN: 07170946) 3. Mrs. Bhandaram Sathyavathi - Non - Executive Director (DIN: 07638353) 4. Mrs. Mounika Pammi - Independent Director (DIN: 11111376) 5. Mr. Suryaprakasa Rao Bommisetti - Independent Director (DIN: 08089189) 6. Mr. Eswar Reddy Putturu - Independent Director (DIN: 11510880) 7. Mr. Suman Mallu - Independent Director (DIN: 10302888) CHIEF FINANCIAL OFFICER Mr. Siva Kumar Vellanki COMPANY SECRETARY AND COMPLIANCE OFFICER Ms. Neha Kankariya REGISTERED OFFICE 601,5th Floor, Oxford Towers, Opp to Leela Palace Hotel, Old Airport Road, Kodihalli Bangalore- 560008, Karnataka Ph.No: 9886531601 Email: info.bandaram@gmail.com CORPORATE IDENTITY NUMBER L93090KA1993PLC159827 BANKERS UCO Bank, Banashankari Branch, Bangalore AUDIT COMMITTEE Mr. Suman Mallu - Chairman Mr. Suryaprakasa Rao Bommisetti - Member Mr. Eswar Reddy Putturu - Member NOMINATION & REMUNERATION COMMITTEE Mr. Suman Mallu - Chairman Mr. Suryaprakasa Rao Bommisetti - Member Mrs. Mounika Pammi - Member STAKEHOLDER RELATIONSHIP COMMITTEE Mr. Suman Mallu - Chairman Mr. Suryaprakasa Rao Bommisetti - Member Mr. Eswar Reddy Putturu - Member INDEPENDENT DIRECTORS Mr. Suryaprakasa Rao Bommisetti Mr. Eswar Reddy Putturu Mrs. Mounika Pammi Mr. Suman Mallu BANDARAM PHARMA PACKTECH LIMITED REGISTRAR & SHARE TRANSFER AGENTS Cameo Corporate Services Limited Subramanian Building No 1, Club House Road, Chennai, Tamil Nadu,600002 Contact No: 040 28460390/28460391 E-mail: cameo@cameoindia.com Website: www.cameoindia.com LISTED AT : BSE Limited ISIN : INE875N01036 WEBSITE : https://www.bandaram.com/ INVESTOR E-MAIL ID : info.bandaram@gmail.com BANDARAM PHARMA PACKTECH LIMITED NOTICE Notice is hereby given that the Annual General Meeting of Members of Bandaram Pharma Packtech Limited for FY 2025-26 will be held on Thursday, the 24thday of September, 2026 at 11.00 a.m. through Video Conferencing/ Other Audio Visual Means (OAVM), to transact the following business: ORDINARY BUSINESS: 1. To consider and adopt the Audited Standalone Financial Statements for the year ended March 31, 2026 and the reports of the Board of Directors and Auditors thereon. 2. To consider and adopt the Audited Consolidated Financial Statements for the year ended March 31, 2026 and the report of the Auditors thereon. 3. To appoint a director in place of Mr. Bhandaram Premsai Reddy (DIN: 07170946), who retires by rotation and being eligible, offers himself for re-appointment. 4. To re-appoint M/s. M.M. Reddy & Co., Chartered Accountants (FRN No. 010371S) as Statutory Auditors of the Company. To consider and if thought fit, to pass, with or without modification(s), the following resolution as an Ordinary Resolution: “RESOLVED THAT pursuant to the provisions of Section 139, 142 and other applicable provisions, if any of the Companies Act, 2013 read with the Companies (Audit and Auditors) Rules, 2014(including any statutory modification(s) or reenactment(s) thereof for the time being in force) and pursuant to the recommendation of the Audit Committee and approval of the Board, M/s. M.M. Reddy & Co., Chartered Accountants, (FRN No. 010371S),be and is hereby re- appointed as the Statutory Auditors of the Company, to hold office for the 2nd term of 3 (three) consecutive years commencing from the conclusion of this Annual General Meeting till the Annual General Meeting of the Company for thefinancial year 2028-29 to be held in the year 2029-30 at a remuneration of Rs. 2,00,000/- per annum (plus applicable taxes and out-of-pocket expenses if any) or as may be mutually decided by the Board and Auditor. “RESOLVED FURTHER THAT Board be and is hereby authorized to take all necessary steps as may be necessary to give effect to the above resolution including filing of all such necessary documents as may be required in this regard.” SPECIAL BUSINESS: 5. RE-APPOINTMENT OF MR. SURYAPRAKASA RAO BOMMISETTI (DIN: 08089189) AS AN INDEPENDENT DIRECTOR OF THE COMPANY To consider and if thought fit, to pass with or without modifications, the following Resolution as Special Resolution: “RESOLVED THAT pursuant to the provisions of Sections 149, 150, 152, Schedule IV and other applicable provisions, if any, of the Companies Act, 2013 (‘the Act’) read with rules made thereunder, SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’) (including any statutory modification(s) or re-enactment(s) thereof for the time being in force) and other applicable laws and the provisions of the Articles of Association of the Company and pursuant to recommendation of the Nomination and Remuneration Committee and approval of the Board of Directors of the Company, Mr. Suryaprakasa Rao Bommisetti (DIN: 08089189), who was appointed as an Independent Director of the Company and who is eligible for re-appointment and has submitted a declaration confirming that he meets the criteria of independence under the Act and the SEBI (LODR) Regulations, 2015,be and is hereby re-appointed as an Independent Director of the Company, not liable to retire by rotation, for a 2nd term of 5 (Five)consecutive years effective from 07.03.2027 to 06.03.2032 (both dates inclusive). BANDARAM PHARMA PACKTECH LIMITED RESOLVED FURTHER THAT the Board be and is hereby authorized to sign and execute all such documents and papers (including appointment letter etc.) as may be required for the purpose and file necessary e-form with the Registrar of Companies and to do all such acts, deeds and things as may be considered expedient and necessary in this regard. For and on behalf of the Board For Bandaram Pharma Packtech Limited Deepak Reddy Bandaram Date: 13.08.2026 Chairman and Managing Director Place: Bengaluru DIN:07074102 BANDARAM PHARMA PACKTECH LIMITED Annexure A: Details of Directors seeking appointment and re-appointment at the forthcoming Annual General Meeting [Pursuant to Regulation 36(3) of the SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015 and Secretarial Standard 2 on Gener [Showing first 8,000 characters — download PDF for full document]